Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 24, 2023
HTLV-1-associated myelopathy in SpainCarmen de-Mendoza, Leire Pérez, Ariadna Rando, et al.IJID Regions|February 2, 2024
Human T-lymphotropic virus-1 infection among Latin American pregnant women living in SpainBegoña Encinas, Rafael Benito, Silvia Rojo, et al.Plos One|April 21, 2016
Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial PlatformsNatalia Chueca, Isidro Rivadulla, Rubén Lovatti, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 11, 2011
Genetic diversity of influenza A(H1N1)2009 virus circulating during the season 2010-2011 in SpainJuan Ledesma, Francisco Pozo, Gabriel Reina, et al.Pathogens and Disease|October 5, 2019
Non-pigmented rapidly growing mycobacteria smooth and rough colony phenotypes pathogenicity evaluated using in vitro and experimental modelsMarta García-Coca, John-Jairo Aguilera-Correa, Arancha Ibáñez-Apesteguía, et al.Journal of Inflammation Research|December 9, 2021
The Differential Expression of the Inflammasomes in Adipose Tissue and Colon Influences the Development of Colon Cancer in a Context of Obesity by Regulating Intestinal InflammationGema Frühbeck, Amaia Mentxaka, Patricia Ahechu, et al.Microbial Biotechnology|March 25, 2023
Optimization of the molecular diagnosis of the acute hepatitis E virus infectionPedro Lopez-Lopez, Mario Frias, Ana Belén Perez-Jimenez, et al.Emerging Microbes & Infections|September 20, 2021
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responsesBelén Aparicio, Noelia Casares, Josune Egea, et al.Trials|June 10, 2020
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trialCarlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 28, 2022
Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategiesCarmen de Mendoza, Leire Pérez, Mario Fernández-Ruiz, et al.Pageof 8